288 related articles for article (PubMed ID: 33846253)
1. Dnmt3a deficiency in the skin causes focal, canonical DNA hypomethylation and a cellular proliferation phenotype.
Chen DY; Ferguson IM; Braun KA; Sutton LA; Helton NM; Ramakrishnan SM; Smith AM; Miller CA; Ley TJ
Proc Natl Acad Sci U S A; 2021 Apr; 118(16):. PubMed ID: 33846253
[TBL] [Abstract][Full Text] [Related]
2. Skeletal abnormalities in mice with Dnmt3a missense mutations.
Bell-Hensley A; Beard DC; Feeney K; Zheng H; Jiang Y; Zhang X; Liu J; Gabel H; McAlinden A
Bone; 2024 Jun; 183():117085. PubMed ID: 38522809
[TBL] [Abstract][Full Text] [Related]
3. Functional and epigenetic phenotypes of humans and mice with DNMT3A Overgrowth Syndrome.
Smith AM; LaValle TA; Shinawi M; Ramakrishnan SM; Abel HJ; Hill CA; Kirkland NM; Rettig MP; Helton NM; Heath SE; Ferraro F; Chen DY; Adak S; Semenkovich CF; Christian DL; Martin JR; Gabel HW; Miller CA; Ley TJ
Nat Commun; 2021 Jul; 12(1):4549. PubMed ID: 34315901
[TBL] [Abstract][Full Text] [Related]
4. Growth disrupting mutations in epigenetic regulatory molecules are associated with abnormalities of epigenetic aging.
Jeffries AR; Maroofian R; Salter CG; Chioza BA; Cross HE; Patton MA; Dempster E; Temple IK; Mackay DJG; Rezwan FI; Aksglaede L; Baralle D; Dabir T; Hunter MF; Kamath A; Kumar A; Newbury-Ecob R; Selicorni A; Springer A; Van Maldergem L; Varghese V; Yachelevich N; Tatton-Brown K; Mill J; Crosby AH; Baple EL
Genome Res; 2019 Jul; 29(7):1057-1066. PubMed ID: 31160375
[TBL] [Abstract][Full Text] [Related]
5. Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndrome.
Tovy A; Rosas C; Gaikwad AS; Medrano G; Zhang L; Reyes JM; Huang YH; Arakawa T; Kurtz K; Conneely SE; Guzman AG; Aguilar R; Gao A; Chen CW; Kim JJ; Carter MT; Lasa-Aranzasti A; Valenzuela I; Van Maldergem L; Brunetti L; Hicks MJ; Marcogliese AN; Goodell MA; Rau RE
Haematologica; 2022 Apr; 107(4):887-898. PubMed ID: 34092059
[TBL] [Abstract][Full Text] [Related]
6. Acute myeloid leukaemia in a case with Tatton-Brown-Rahman syndrome: the peculiar
Hollink IHIM; van den Ouweland AMW; Beverloo HB; Arentsen-Peters STCJM; Zwaan CM; Wagner A
J Med Genet; 2017 Dec; 54(12):805-808. PubMed ID: 28432085
[TBL] [Abstract][Full Text] [Related]
7. An adult patient with Tatton-Brown-Rahman syndrome caused by a novel DNMT3A variant and axonal polyneuropathy.
AlSabah AA; Alsalmi M; Massie R; Bilodeau MC; Campeau PM; McGraw S; D'Agostino MD
Am J Med Genet A; 2024 Apr; 194(4):e63484. PubMed ID: 38041495
[TBL] [Abstract][Full Text] [Related]
8. Expanding the phenotype of DNMT3A as a cause a congenital myopathy with rhabdomyolysis.
Ghaoui R; Ha TT; Kerkhof J; McConkey H; Gao S; Babic M; King R; Ravenscroft G; Koszyca B; Otto S; Laing NG; Scott H; Sadikovic B; Kassahn KS
Neuromuscul Disord; 2023 Jun; 33(6):484-489. PubMed ID: 37209493
[TBL] [Abstract][Full Text] [Related]
9. The spectrum of DNMT3A variants in Tatton-Brown-Rahman syndrome overlaps with that in hematologic malignancies.
Shen W; Heeley JM; Carlston CM; Acuna-Hidalgo R; Nillesen WM; Dent KM; Douglas GV; Levine KL; Bayrak-Toydemir P; Marcelis CL; Shinawi M; Carey JC
Am J Med Genet A; 2017 Nov; 173(11):3022-3028. PubMed ID: 28941052
[TBL] [Abstract][Full Text] [Related]
10. Acute myeloid leukemia-associated DNMT3A p.Arg882His mutation in a patient with Tatton-Brown-Rahman overgrowth syndrome as a constitutional mutation.
Kosaki R; Terashima H; Kubota M; Kosaki K
Am J Med Genet A; 2017 Jan; 173(1):250-253. PubMed ID: 27991732
[TBL] [Abstract][Full Text] [Related]
11. Further delineation of neuropsychiatric findings in Tatton-Brown-Rahman syndrome due to disease-causing variants in DNMT3A: seven new patients.
Tenorio J; Alarcón P; Arias P; Dapía I; García-Miñaur S; Palomares Bralo M; Campistol J; Climent S; Valenzuela I; Ramos S; Monseny AM; Grondona FL; Botet J; Serrano M; Solís M; Santos-Simarro F; Álvarez S; Teixidó-Tura G; Fernández Jaén A; Gordo G; Bardón Rivera MB; Nevado J; Hernández A; Cigudosa JC; Ruiz-Pérez VL; Tizzano EF; ; Lapunzina P
Eur J Hum Genet; 2020 Apr; 28(4):469-479. PubMed ID: 31685998
[TBL] [Abstract][Full Text] [Related]
12. Tatton-Brown-Rahman syndrome: Novel pathogenic variants and new neuroimaging findings.
Jiménez de la Peña M; Rincón-Pérez I; López-Martín S; Albert J; Martín Fernández-Mayoralas D; Fernández-Perrone AL; Jiménez de Domingo A; Tirado P; Calleja-Pérez B; Porta J; Álvarez S; Fernández-Jaén A
Am J Med Genet A; 2024 Feb; 194(2):211-217. PubMed ID: 37795572
[TBL] [Abstract][Full Text] [Related]
13. Tatton-Brown-Rahman syndrome due to 2p23 microdeletion.
Okamoto N; Toribe Y; Shimojima K; Yamamoto T
Am J Med Genet A; 2016 May; 170A(5):1339-42. PubMed ID: 26866722
[TBL] [Abstract][Full Text] [Related]
14. Aortic root dilatation and dilated cardiomyopathy in an adult with Tatton-Brown-Rahman syndrome.
Cecchi AC; Haidar A; Marin I; Kwartler CS; Prakash SK; Milewicz DM
Am J Med Genet A; 2022 Feb; 188(2):628-634. PubMed ID: 34644003
[TBL] [Abstract][Full Text] [Related]
15. Novel DNMT3A germline mutations are associated with inherited Tatton-Brown-Rahman syndrome.
Xin B; Cruz Marino T; Szekely J; Leblanc J; Cechner K; Sency V; Wensel C; Barabas M; Therriault V; Wang H
Clin Genet; 2017 Apr; 91(4):623-628. PubMed ID: 27701732
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability.
Tatton-Brown K; Seal S; Ruark E; Harmer J; Ramsay E; Del Vecchio Duarte S; Zachariou A; Hanks S; O'Brien E; Aksglaede L; Baralle D; Dabir T; Gener B; Goudie D; Homfray T; Kumar A; Pilz DT; Selicorni A; Temple IK; Van Maldergem L; Yachelevich N; ; van Montfort R; Rahman N
Nat Genet; 2014 Apr; 46(4):385-8. PubMed ID: 24614070
[TBL] [Abstract][Full Text] [Related]
17. Constitutive loss of DNMT3A causes morbid obesity through misregulation of adipogenesis.
Tovy A; Reyes JM; Zhang L; Huang YH; Rosas C; Daquinag AC; Guzman A; Ramabadran R; Chen CW; Gu T; Gupta S; Ortinau L; Park D; Cox AR; Rau RE; Hartig SM; Kolonin MG; Goodell MA
Elife; 2022 May; 11():. PubMed ID: 35635747
[TBL] [Abstract][Full Text] [Related]
18. Acromegaly in the setting of Tatton-Brown-Rahman Syndrome.
Hage C; Sabini E; Alsharhan H; Fahrner JA; Beckers A; Daly A; Salvatori R
Pituitary; 2020 Apr; 23(2):167-170. PubMed ID: 31858400
[TBL] [Abstract][Full Text] [Related]
19. KMT2C deficiency promotes small cell lung cancer metastasis through DNMT3A-mediated epigenetic reprogramming.
Na F; Pan X; Chen J; Chen X; Wang M; Chi P; You L; Zhang L; Zhong A; Zhao L; Dai S; Zhang M; Wang Y; Wang B; Zheng J; Wang Y; Xu J; Wang J; Wu B; Chen M; Liu H; Xue J; Huang M; Gong Y; Zhu J; Zhou L; Zhang Y; Yu M; Tian P; Fan M; Lu Z; Xue Z; Zhao Y; Yang H; Zhao C; Wang Y; Han J; Yang S; Xie D; Chen L; Zhong Q; Zeng M; Lowe SW; Lu Y; Liu Y; Wei Y; Chen C
Nat Cancer; 2022 Jun; 3(6):753-767. PubMed ID: 35449309
[TBL] [Abstract][Full Text] [Related]
20. [Tatton-Brown-Rahman syndrome associated with the DNMT3A gene: a case report and literature review].
Chen M; Li ST; Cai Y; Xiao X; Shi CC; Hao H
Zhongguo Dang Dai Er Ke Za Zhi; 2020 Oct; 22(10):1114-1118. PubMed ID: 33059810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
